Literature DB >> 7532669

Bone marrow-derived murine mast cells migrate, but do not degranulate, in response to chemokines.

D Taub1, J Dastych, N Inamura, J Upton, D Kelvin, D Metcalfe, J Oppenheim.   

Abstract

We have determined that several chemokines induce mast cell migration in vitro. This directed migration is dependent on the presence of particular extracellular matrix proteins and the activation status of the cells. Mast cell haptotactic responses were observed in response to various chemokines on vitronectin-, laminin-, and fibronectin-coated filters. Unstimulated mast cells were chemoattracted only by monocyte chemotactic protein-1 and RANTES on vitronectin-coated and, to a lesser extent, laminin-coated filters, whereas IgE-activated mast cells migrated in response to monocyte chemotactic protein-1, regulated on activation normal T expressed and secreted, platelet factor-4, and macrophage inflammatory protein-1 alpha on all three matrix proteins. No significant migration was observed on collagen type IV-coated or uncoated filters. Mast cell migration in response to chemokines on extracellular matrices and its enhancement by IgE-dependent activation provide a mechanism by which cells may be drawn to sites of inflammation. Chemokine-induced mast cell recruitment may be particularly relevant in host defense responses to parasitic infections, allergic reactions, Jones-Mote reactions, and in wound healing.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7532669

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

1.  The role of the CCL2/CCR2 axis in mouse mast cell migration in vitro and in vivo.

Authors:  Sarah J Collington; Jenny Hallgren; James E Pease; Tatiana G Jones; Barrett J Rollins; John Westwick; K Frank Austen; Timothy J Williams; Michael F Gurish; Charlotte L Weller
Journal:  J Immunol       Date:  2010-04-28       Impact factor: 5.422

Review 2.  Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic.

Authors:  Jian Zhang; Lalit Patel; Kenneth J Pienta
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

Review 3.  G protein-coupled receptors and the modification of FcepsilonRI-mediated mast cell activation.

Authors:  Hye Sun Kuehn; Alasdair M Gilfillan
Journal:  Immunol Lett       Date:  2007-09-18       Impact factor: 3.685

4.  Developmental changes of mast cell populations in the cerebral meninges of the rat.

Authors:  Helen Michaloudi; Christos Batzios; Maria Chiotelli; Georgios C Papadopoulos
Journal:  J Anat       Date:  2007-09-06       Impact factor: 2.610

Review 5.  Molecular regulation of mast cell development and maturation.

Authors:  Chenxiong Liu; Zhigang Liu; Zhilong Li; Yaojiong Wu
Journal:  Mol Biol Rep       Date:  2009-07-31       Impact factor: 2.316

6.  Molecular mechanisms of spontaneous and directed mast cell motility.

Authors:  Jinmin Lee; Sarah L Veatch; Barbara Baird; David Holowka
Journal:  J Leukoc Biol       Date:  2012-08-02       Impact factor: 4.962

7.  Oxidized CaMKII promotes asthma through the activation of mast cells.

Authors:  Jingjing Qu; Danh C Do; Yufeng Zhou; Elizabeth Luczak; Wayne Mitzner; Mark E Anderson; Peisong Gao
Journal:  JCI Insight       Date:  2017-01-12

8.  Effects of basophil-priming and stimulating cytokines on histamine release from isolated human skin mast cells.

Authors:  M Nitschke; K Sohn; D Dieckmann; B F Gibbs; H H Wolff; U Amon
Journal:  Arch Dermatol Res       Date:  1996-07       Impact factor: 3.017

9.  Intracellular RNA recognition pathway activates strong anti-viral response in human mast cells.

Authors:  J Lappalainen; J Rintahaka; P T Kovanen; S Matikainen; K K Eklund
Journal:  Clin Exp Immunol       Date:  2013-04       Impact factor: 4.330

10.  Expression of antizyme inhibitor 2 in mast cells and role of polyamines as selective regulators of serotonin secretion.

Authors:  Kristiina Kanerva; Jani Lappalainen; Laura T Mäkitie; Susanna Virolainen; Petri T Kovanen; Leif C Andersson
Journal:  PLoS One       Date:  2009-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.